植え込み型医療機器の世界市場：市場規模（製品種類別・材料の種類別・エンドユーザー別・地域別）、将来予測

植え込み型医療機器の市場規模と予測

植え込み型医療機器の市場規模は、2024年に1,084億4,000万米ドルと評価され、2026年から2032年にかけてCAGR 6.52%で成長し、2032年には1,797億3,000万米ドルに達すると予測されます。

植え込み型医療機器（IMD）は、医療問題の治療、生理学的パラメータのモニター、治療補助のために人体に植え込まれる特殊な機器や器具です。これらの機器は通常、身体組織や機能との適合性を確保するために生体適合材料で構成されています。ペースメーカー、人工内耳、インスリンポンプ、神経刺激装置などがその例です。

IMDは、集中的な投薬やバイタルサインの継続的なモニタリングにより、心血管疾患、糖尿病、神経障害などの慢性疾患の管理において重要な役割を果たしています。IMDを体内に組み込むことで、必要な時点に直接介入することが可能になり、治療の侵襲性が軽減され、患者の転帰が改善される可能性があります。

これらの医療機器は、幅広い医療分野でますます使用されるようになっています。リアルタイムでデータをモニターし、適応的に対応することで、正確で個別化された医療介入を提供します。IMD技術の将来的な改良は、機能性、耐久性、小型化を向上させ、問題のリスクを下げ、患者の快適性を高めることを目指しています。生体吸収性インプラント、遠隔モニタリングのためのワイヤレス接続、予測診断のための人工知能の統合は、すべて将来の潜在的開発です。

IMDはまた、バイオエレクトロニクスや再生医療などの開発分野でも有望視されており、そこでは従来の医療技術を超えて身体機能の回復や改善に重要な役割を果たす可能性があります。

植え込み型医療機器の世界市場力学

世界の植え込み型医療機器市場を形成している主な市場力学は以下の通りである：

主な市場促進要因

人口の高齢化：人口の高齢化は、植え込み型医療機器の需要を促進します。世界保健機関（WHO）によると、世界人口に占める60歳以上の割合は2015年から2050年の間に12%から22%へとほぼ倍増すると予測されています。この人口動態の変化により、加齢に関連した疾病の有病率が増加しており、その多くは植え込み型医療機器を必要とします。

医療支出の増加：世界の医療支出は増加しており、最新医療技術の採用率上昇につながっています。メディケア＆メディケイドサービスセンターは、米国の国民医療費は2019年から2028年にかけて年平均5.4%増加し、2028年には6兆2,000億米ドルに達すると予測しています。

技術の進歩：インプラント機器の技術的進歩は、患者の転帰を改善しています。2020年、米国食品医薬品局（FDA）は59の革新的な医療機器を認可したが、その多くは植え込み型であり、この分野の急速な進歩を示しています。

主な課題

生体適合性と材料の選択：炎症や拒絶反応といった不快な反応を避けるため、植え込み型医療機器（IMD）は人体に適合する材料で作られなければならないです。生体適合性試験と生体材料科学の向上は、安全性と性能を高める努力を続けています。

患者の受容と心理的影響：患者がIMDを受け入れるかどうかは、手術、装置の視認性、心理的影響などの要因によって異なります。IMDの利点とリスクについて患者や医療提供者を教育することは、十分な知識を持った上で決断を下し、患者の受容率を高めるために極めて重要です。

手術手技と植え込み手順：IMDの植え込みには、損傷や感染のリスクを軽減すると同時に、体内の正しい位置を確保するための正確な外科的技術や技能が必要です。低侵襲手術やロボット支援技術の進歩は、こうした課題の解決に役立っています。

コストと手頃な価格：IMDの開発・製造には多額の研究費、製造費、規制費用がかかるため、患者の経済的な負担や利用しやすさに影響を及ぼす可能性があります。技術革新と費用対効果のバランスをとることは、現在進行中の課題です。

主要動向：

ワイヤレス接続と遠隔モニタリングワイヤレス接続機能を備えた植え込み型医療機器（IMD）は、医療提供者にリアルタイムでデータを送信できるため、遠隔モニタリング機能が向上します。この動きは、プロアクティブな医療管理、早期介入、患者固有の情報に基づく個別の治療調整を促進します。

スマートインプラントと人工知能：AIの進歩は、適応的かつ定期的に反応できるスマートインプラントの創出を促しています。これらのインプラントは、生理学的データを自動的にモニターし、異常を検出して治療を変更することができるため、治療効果と患者の転帰が向上します。

患者中心の設計：患者の快適さ、美しさ、使いやすさを優先したIMDを作ろうという動向があります。ユーザーフレンドリーなインターフェイス、人間工学に基づいた設計、統合された患者フィードバックはすべて、治療の受容性とアドヒアランスを高めるのに役立ちます。

世界市場の拡大：IMD市場は、医療コストの上昇、人口の高齢化、慢性疾患の蔓延の増加により拡大しています。アジア太平洋とラテンアメリカの新興国は、医療インフラの改善と患者の拡大により、IMDメーカーに成長の可能性をもたらしています。

目次

第1章 世界の植え込み型医療機器市場：イントロダクション

• 市場概要
• 分析範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの分析手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の植え込み型医療機器市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル

第5章 世界の植え込み型医療機器市場：製品種類別

• 概要
• 心血管インプラント
• 整形外科インプラント
• 乳房インプラント
• 歯科用インプラント
• 眼科インプラント
• 人工内耳インプラント

第6章 世界の植え込み型医療機器市場：材料の種類別

• 概要
• 金属
• セラミック
• ポリマー

第7章 世界の植え込み型医療機器市場：エンドユーザー別

• 概要
• 病院
• 外来手術センター
• 総合クリニック

第8章 世界の植え込み型医療機器市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋
• その他の地域 (ROW)
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の植え込み型医療機器市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Medtronic Plc
• Abbott Laboratories
• Boston Scientific Corporation
• Stryker Corporation
• Johnson & Johnson
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew Plc
• BIOTRONIK SE & Co
• LivaNova Plc
• Cochlear Limited

第11章 主な動向

• 製品上市/開発
• 企業合併・買収 (M&A)
• 事業拡大
• 提携・協力

第12章 付録

• 関連分析

Implantable Medical Devices Market Size And Forecast

Implantable Medical Devices Market size was valued at USD 108.44 Billion in 2024 and is projected to reach USD 179.73 Billion by 2032, growing at a CAGR of 6.52% from 2026 to 2032.

Implantable medical devices (IMDs) are specialized equipment or appliances that are implanted into the human body to treat medical problems, monitor physiological parameters, or give therapeutic assistance. These devices are usually composed of biocompatible materials to ensure compatibility with bodily tissues and functions. Pacemakers, cochlear implants, insulin pumps, and neurostimulators are some such examples.

IMDs play an important role in the management of chronic ailments such as cardiovascular disease, diabetes, and neurological disorders by providing focused medications and continuously monitoring vital signs. Their incorporation into the body enables direct intervention at the point of need, reducing the invasiveness of treatments and perhaps enhancing patient outcomes.

These devices are increasingly being used across a wide range of medical fields. They provide accurate and individualized healthcare interventions by monitoring data in real time and responding adaptively. Future improvements in IMD technology aim to improve functionality, durability, and miniaturization, lowering the risk of problems and increasing patient comfort. Bioresorbable implants, wireless connectivity for remote monitoring, and artificial intelligence integration for predictive diagnosis are all potential developments for the future.

IMDs have also shown promise in developing disciplines such as bioelectronics and regenerative medicine, where they potentially play critical roles in restoring and improving bodily functioning beyond traditional medical techniques.

Global Implantable Medical Devices Market Dynamics

The key market dynamics that are shaping the global implantable medical devices market include:

Key Market Drivers:

Aging Population: The aging population drives demand for implantable medical devices. According to the World Health Organization, the proportion of the global population over the age of 60 is anticipated to nearly double between 2015 and 2050, from 12% to 22%. This demographic change is increasing the prevalence of age-related illnesses, many of which require implanted devices.

Increasing Healthcare Expenditure: Global healthcare spending is increasing, leading to higher adoption of modern medical technologies. The Centers for Medicare & Medicaid Services predicted that national health spending in the United States would increase at an average annual rate of 5.4% between 2019 and 2028, reaching $6.2 trillion by 2028.

Technological Advancements: Technological advancements in implanted devices are improving patient outcomes. In 2020, the US Food and Drug Administration (FDA) authorized 59 innovative medical devices, many of which were implantable, demonstrating the field's rapid advancement.

Key Challenges:

Biocompatibility and Material Selection: To avoid unpleasant reactions like inflammation or rejection, implantable medical devices (IMDs) must be made from materials that are compatible with the human body. Biocompatibility testing and improvements in biomaterial science are continuing efforts to enhance safety and performance.

Patient Acceptance and Psychological Impact: Patients' acceptance of IMDs can vary depending on factors such as surgery, device visibility, and psychological effects. Educating patients and healthcare providers on the benefits and risks of IMDs is critical for making educated decisions and increasing patient acceptance rates.

Surgical Techniques and Implantation Procedures: IMD implantation involves precise surgical skills and techniques to reduce damage and infection risks while also ensuring the correct location within the body. Advances in minimally invasive surgery and robotic-assisted techniques are helping to resolve these challenges.

Cost and Affordability: The development and production of IMDs incur significant research, manufacturing, and regulatory expenditures, which might have an impact on patient affordability and accessibility. Balancing innovation with cost-effectiveness is an ongoing challenge.

Key Trends:

Wireless Connectivity and Remote Monitoring: Implantable Medical Devices (IMDs) with wireless connectivity can transmit real-time data to healthcare providers, which improves remote monitoring capabilities. This movement promotes proactive healthcare management, early intervention, and individualized therapy adjustments based on patient-specific information.

Smart Implants and Artificial Intelligence: Advances in AI are encouraging the creation of smart implants that can respond adaptively and regularly. These implants can automatically monitor physiological data, detect anomalies, and alter therapy, thereby enhancing treatment efficacy and patient outcomes.

Patient-Centric Design: There is a trend toward creating IMDs that prioritize patient comfort, aesthetics, and usability. User-friendly interfaces, ergonomic designs, and integrated patient feedback all help to increase therapy acceptance and adherence.

Global Market Expansion: The IMD market is growing due to rising healthcare costs, aging populations, and an increasing prevalence of chronic diseases. Emerging countries in Asia-Pacific and Latin America offer growth possibilities for IMD producers, driven by improved healthcare infrastructure and expanding patient.

Global Implantable Medical Devices Market Regional Analysis

Here is a more detailed regional analysis of the global implantable medical devices market:

North America:

North America currently holds the dominant position in the implantable medical device market. The North American region, particularly the United States and Canada, has a high prevalence of chronic diseases, which drives demand for implantable medical devices (IMDs). According to Centers for Disease Control and Prevention (CDC) data from 2022, 60% of adults in the United States had at least one chronic disease, with 40% having two or more. According to the American Heart Association, cardiovascular disorders impact 48% of US people in 2019 and remain a leading cause of death.

Furthermore, the International Diabetes Federation estimates that diabetes prevalence in North America will reach 49.9 million individuals by 2045, up from 37.7 million in 2021. These worrisome rates highlight the vital need for innovative treatment modalities such as pacemakers, implanted cardioverter-defibrillators, and insulin pumps, resulting in significant growth in the IMD market throughout the region.

North America's robust healthcare system, particularly in the United States and Canada, is a key driver of the implanted medical devices (IMDs) market. According to the American Hospital Association, there will be over 6,000 hospitals in the United States by 2023 that are equipped with cutting-edge equipment capable of performing complicated implant procedures.

North America has a large concentration of competent healthcare professionals, with the United States alone accounting for over 758,500 active physicians and surgeons, according to the Bureau of Labor Statistics. This vast network of qualified specialists skilled in IMD procedures promotes the effective adoption and deployment of breakthrough medical technology, accelerating market progress throughout the region.

Asia Pacific:

The Asia Pacific region is poised for the fastest growth in the implantable medical device market. Government initiatives in the Asia-Pacific region are essential to driving the growth of the implantable medical devices (IMD) market. Healthcare expenditure in Southeast Asia has increased significantly in recent years, growing from 3.5% of GDP in 2000 to 4.4% in 2018, according to the World Health Organization. This growing trend indicates increased investment in healthcare infrastructure and services.

The Asia-Pacific implantable medical devices (IMDs) market is experiencing strong growth, driven by demographic factors such as a growing population and increasingly aging demographics. According to the United Nations Economic and Social Commission for Asia and the Pacific (UNESCAP), the region's population is expected to grow from 4.3 billion in 2020 to 4.7 billion in 2050. The proportion of people over the age of 65 is predicted to double from 13% in 2020 to 26% in 2050 across Asia and the Pacific.

Global Implantable Medical Devices Market: Segmentation Analysis

The Global Implantable Medical Devices Market is Segmented on the basis of Product Type, Material Type, End-User, And Geography.

Implantable Medical Devices Market, By Product Type

• Cardiovascular Implants
• Orthopedic Implants
• Breast Implants
• Dental Implants
• Ophthalmic Implants
• Cochlear Implants

Based on Product Type, the market is bifurcated into Cardiovascular Implants, Orthopedic Implants, Breast Implants, Breast Implants, Dental Implants, Ophthalmic Implants, and Cochlear Implants. Cardiovascular implants dominate the implanted medical device market. This is because cardiovascular disorders are extremely common over the world. However, orthopedic implants are predicted to rise the fastest due to an aging population and increased need for joint replacements and fracture treatment solutions.

Implantable Medical Devices Market, By Material Type

• Metallic
• Ceramic
• Polymer

Based on Material Type, the market is segmented into Metallic, Ceramic, and Polymer. Metals are currently the most common materials utilized in implantable medical devices. This is because they provide higher strength, durability, and biocompatibility in applications such as bone plates, joint replacements, and stents. However, polymers are projected to be the fastest-expanding category. Their advantages, such as flexibility, cheaper cost, and suitability for drug delivery, are driving their widespread use in catheters, heart valves, and wound dressings.

Implantable Medical Devices Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Multi-Specialty Clinics

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Multi-Specialty Clinics. Hospitals dominate the implantable medical device market. This is owing to their ability to perform sophisticated procedures, house advanced technology, and provide specialized treatment for chronic disorders that frequently necessitate implantable devices. However, ambulatory surgical facilities (ASCs) experience the most rapid expansion. This trend is being driven by the rising acceptance of minimally invasive procedures, lower costs when compared to hospitals, and a growing patient preference for convenient outpatient settings.

Key Players

The "Global Implantable Medical Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Stryker Corporation, Zimmer Biomet Holdings, Inc., Johnson & Johnson, Smith & Nephew Plc, BIOTRONIK SE & Co. KG, LivaNova Plc, Cochlear Limited. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Implantable Medical Devices Market Recent Developments
• In October 2019, Medtronic got FDA breakthrough device designation for their fully implantable left ventricular assist device (LVAD) for patients with advanced heart failure. This accreditation will allow the company to deliver more effective therapy or diagnostics for life-threatening diseases, increasing its business size.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model

5 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY PRODUCT TYPE

• 5.1 Overview
• 5.2 Cardiovascular Implants
• 5.3 Orthopedic Implants
• 5.4 Breast Implants
• 5.5 Dental Implants
• 5.6 Ophthalmic Implants
• 5.7 Cochlear Implants

6 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY MATERIAL TYPE

• 6.1 Overview
• 6.2 Metallic
• 6.3 Ceramic
• 6.4 Polymer

7 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY END- USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Ambulatory Surgical Centers
• 7.4 Multi-Specialty Clinics

8 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East & Africa

9 GLOBAL IMPLANTABLE MEDICAL DEVICES MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Medtronic Plc
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Abbott Laboratories
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Boston Scientific Corporation
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Stryker Corporation
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Johnson & Johnson
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Zimmer Biomet Holdings, Inc.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Smith & Nephew Plc
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 BIOTRONIK SE & Co
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 LivaNova Plc
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Cochlear Limited
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research